Advanced Therapies Congress 2026
Europe’s premier cell & gene therapy summit returns to London
The 2026 edition of the Advanced Therapies Congress will take place on 17–18 March 2026 at ExCeL London. Over two days, the conference will bring together roughly 3,300 global executives, featuring 300 speakers and showcasing about 75 start‑ups.
The event is widely regarded as Europe’s largest commercial conference and exhibition dedicated to advanced therapies — in particular, cell and gene medicines (ATMPs). It attracts senior leaders from biotechnology and pharmaceutical companies, start‑ups, academic researchers, clinicians, regulatory agencies, and payers.
The 2026 agenda covers the full spectrum of the therapy‑development pipeline: from early‑stage research and cell/gene engineering to manufacturing, supply chain, regulatory strategy, reimbursement, and market access.
For many organisations working in regenerative medicine or gene therapy, this Congress is a key opportunity for networking, collaboration and staying abreast of latest innovations.
For full details, see the official site:https://www.terrapinn.com/congress/advanced-therapies/index.stm
Image credit: AdobeStock.com
March 17, 2026 - March 18, 2026
